The risk of cancer in patients with rheumatoid arthritis: A nationwide cohort study in Taiwan
Authors:
Open Access
- 4 November 2010
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 63 (2) , 352-358
Abstract
Objective: The association of rheumatoid arthritis (RA) and malignancy has rarely been explored in Asian populations. The aim of this study was to investigate the relative risk of cancer in Taiwanese patients with RA and to identify groups of patients with a high risk of cancer.Methods: We conducted a nationwide cohort study of the risk of cancer among 23,644 patients with RA who had no history of malignancies, using the National Health Insurance database of Taiwan from 1996 to 2007. Standardized incidence ratios (SIRs) for various cancers were analyzed.Results: Among the patients with RA, 935 cancers were observed. Patients with RA had an increased risk of cancer (SIR 1.23, 95% confidence interval [95% CI] 1.22–1.23), especially hematologic cancers (SIR 2.74, 95% CI 2.68–2.81). The relative risk of cancer was higher among younger patients. Most cancer cases were detected within the first year following the diagnosis of RA. The relative risk of cancer decreased as the duration of observation increased. Among hematologic cancers, the risk of non‐Hodgkin's lymphoma was greatest (SIR 3.54, 95% CI 3.45–3.63). Among solid tumors, the risk of cancers of the kidney and vagina/vulva was highest. A decreased risk of cancers of the cervix and nonmelanoma skin cancer in patients with RA was also observed.Conclusion: Patients with RA have an increased risk of cancer, especially hematologic and kidney cancers. The relative risk of cancer in patients with RA decreased with long‐term followup. Cancer screening with continued vigilance is recommended for patients with RA.Keywords
This publication has 41 references indexed in Scilit:
- Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseasesArthritis Research & Therapy, 2009
- Cancer in Rheumatoid Arthritis: Occurrence, Mortality, and Associated Factors in a South European PopulationSeminars in Arthritis and Rheumatism, 2008
- Biologic treatment of rheumatoid arthritis and the risk of malignancy: Analyses from a large US observational studyArthritis & Rheumatism, 2007
- Influence of inflammatory polyarthritis on cancer incidence and survival: Results from a community‐based prospective studyArthritis & Rheumatism, 2007
- Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonistsAnnals of the Rheumatic Diseases, 2005
- Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomasAnnals of the Rheumatic Diseases, 2005
- Associations between rheumatoid arthritis and malignancyRheumatic Disease Clinics of North America, 2004
- Risk of malignancy among patients with rheumatic conditionsInternational Journal of Cancer, 2000
- Changes in the incidence and prevalence of rheumatoid arthritis in Kamitonda, Wakayama, Japan, 1965–1996Annals of the Rheumatic Diseases, 1999
- Rheumatoid arthritis and the risk of malignancyArthritis & Rheumatism, 1997